Exelixis director exercises options, sells 20,634 shares
EXELIXIS, INC. director Maria C. Freire reported an exercise-and-sale transaction in company stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
EXELIXIS, INC. director Maria C. Freire reported an exercise-and-sale transaction in company stock. On May 7, 2026, she exercised options to acquire 20,634 shares of Common Stock at $19.77 per share, then sold 20,634 shares in an open-market sale at $46.00 per share.
After these transactions, she directly holds 100,819 shares of Common Stock, which include 9,812 shares that will be issued upon vesting of restricted stock units. The option exercised covered 20,634 shares, became fully exercisable on May 23, 2019, and now has no remaining balance.
Insider Trade Summary
Exercise and Sale: 20,634 shares ($541K approx. pre-tax spread)
Exercise and Sale
3 txns
Insider
Freire Maria C
Role
Director
Sold
20,634 shs ($949K)
Approx. gross sale proceeds
$949K
Approx. exercise cost
$408K
Approx. pre-tax spread
$541K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Option (right to buy) | 20,634 | $0.00 | $0.00 |
| Exercise | Common Stock | 20,634 | $19.77 | $408K |
| Sale | Common Stock | 20,634 | $46.00 | $949K |
Holdings After Transaction:
Option (right to buy) — 0 contracts (Direct);
Common Stock — 100,819 shares (Direct)
Footnotes (2)
- F1. Includes 9,812 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.
- F2. The option, representing the right to purchase a total of 20,634 shares of Common Stock, became fully exercisable on May 23, 2019.
Key Figures
Shares sold: 20,634 shares
Sale price: $46.00 per share
Option exercise price: $19.77 per share
+5 more
8 metrics
Shares sold
20,634 shares
Common Stock sold at $46.00 on May 7, 2026
Sale price
$46.00 per share
Open-market sale of Exelixis Common Stock
Option exercise price
$19.77 per share
Exercise of option for 20,634 shares
Shares acquired via exercise
20,634 shares
Common Stock from derivative exercise on May 7, 2026
Shares held after transactions
100,819 shares
Director’s direct Common Stock holdings following transactions
RSUs outstanding
9,812 shares
Shares to be issued upon vesting of RSUs
Option grant size
20,634 shares
Option became fully exercisable on May 23, 2019
Option expiration
May 22, 2026
Expiration date of exercised option right to buy shares
Key Terms
restricted stock units ("RSUs"), economic equivalent, derivative security, Option (right to buy), +1 more
5 terms
restricted stock units ("RSUs") financial
"shares of Common Stock that will be issued upon vesting of restricted stock units ("RSUs")"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
economic equivalent financial
"Each RSU is the economic equivalent of one share of Common Stock"
derivative security financial
"transaction code description: Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
Option (right to buy) financial
"security_title: Option (right to buy)"
open-market sale financial
"transaction_action: open-market sale"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Exelixis (EXEL) director Maria C. Freire report in this Form 4?
Director Maria C. Freire reported exercising stock options and selling Exelixis shares. She exercised options for 20,634 Common shares at $19.77 each, then sold 20,634 shares at $46.00, and now directly holds 100,819 shares, including unvested RSUs.
What stock options did Maria C. Freire exercise in Exelixis (EXEL)?
She exercised an option covering 20,634 Exelixis Common shares with a $19.77 exercise price. The option was fully exercisable since May 23, 2019, and after this transaction the reported option balance is zero, indicating the entire grant was exercised.
What are the restricted stock units (RSUs) reported for Exelixis (EXEL)?
The filing notes 9,812 Exelixis RSUs that will convert into Common Stock upon vesting. Each RSU is economically equivalent to one share of Common Stock, meaning they add to Maria C. Freire’s future share ownership once the vesting conditions are met.
Was this Exelixis (EXEL) Form 4 mainly a stock option exercise and sale?
Yes. The Form 4 shows a combined option exercise and share sale. Maria C. Freire exercised options for 20,634 shares at $19.77 and sold 20,634 shares at $46.00 the same day, while maintaining a remaining direct position of 100,819 shares.
AI-generated analysis. How Rhea-AI works. Not financial advice.
